Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-1.66%
SPX
-1.04%
IXIC
-1.13%
FTSE
-0.02%
N225
+0.78%
AXJO
-0.21%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals

ACLX is now overvalued and could go down -43%

Jan 03, 2026, 1:00 PM
0.00%
What does ACLX do
Arcellx, based in Redwood City, California, focuses on innovative immunotherapies for cancer, with its lead product, CART-ddBCMA, in pivotal Phase II trials for multiple myeloma. The company also develops two clinical-stage programs targeting BCMA and CD123 in various blood cancers.
Based on our analysis, Arcellx has received an overvalued rating of 1 out of 5 stars from Cashu. Several key financial ratios indicate that the company is underperforming compared to its sector, leading to concerns about its valuation. First, the company’s net profit margin stands at -99.46, while the sector average is -134.62. A net profit margin represents the percentage of revenue that remains as profit after all expenses are deducted. In this case, Arcellx's less negative margin suggests that the company is less efficient in managing its costs relative to its sector. Additionally, Arcellx reports a return on equity (ROE) ratio of -23.60, significantly better than the sector average of -74.11. The ROE ratio measures a company's profitability by revealing how much profit it generates with shareholders' equity. Despite being less negative than the sector, a negative ROE indicates that the company is not effectively generating returns for its investors. Furthermore, Arcellx's return on assets (ROA) ratio is -15.09, while the sector average is -47.59. The ROA ratio shows how efficiently a company uses its assets to generate profit. Again, while Arcellx performs better than the sector, it still shows a lack of profitability. Overall, these financial ratios reflect that Arcellx is struggling relative to its industry, contributing to its overvalued rating. This is not a comprehensive overview of our valuation, and should not be viewed as financial advice. Always do your own research before considering an investment.
📡️ Health Care
Overvalued

More Signals

Feature in Progress
This section is under development. Check back soon for updates!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.